HR-9830-119
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by Andy Barr (R-KY)
What it does
This bill would narrow the legal definition of "hemp" to exclude synthetically modified cannabinoids (such as HHC, THC-O-acetate, and THCP) and set a lower THC concentration threshold of 1% (down from 0.3% in current law for some purposes). It would place hemp-derived cannabinoid products under FDA oversight with mandatory labeling, per-serving THC milligram limits, domestic sourcing requirements, and a minimum purchase age of 21. It would also impose new federal excise taxes — 5 cents per milligram of THC on hemp beverages and 5% of sale price on other hemp cannabinoid products — channeling revenue into a dedicated oversight trust fund, with a small share directed to impaired-driving enforcement.
Who benefits
Licensed hemp farmers growing naturally occurring cannabinoid crops, who would gain clearer legal standing and a regulated market. Compliant hemp product manufacturers who would benefit from a defined federal framework and reduced competition from unregulated synthetic products. Consumers seeking product safety, accurate labeling, and verified THC content. Veterans, seniors, and chronically ill Medicare Advantage enrollees, who could access hemp-derived cannabinoid products as a covered supplemental benefit. Children and minors, who would be protected by the age-21 purchase restriction and child-resistant, non-appealing packaging rules. State and local law enforcement agencies, which would receive funding for impaired-driving detection. Independent testing laboratories accredited to ISO/IEC 17025 standards, which would see increased demand for their services.
Who is hurt
Manufacturers and retailers of synthetic cannabinoid products (HHC, THC-O, THCP, delta-8 THC derived through chemical conversion), whose products would be excluded from the legal hemp definition and effectively banned from interstate commerce. Small hemp businesses that may struggle to absorb compliance costs for labeling, testing, permitting, and tax reporting. Consumers who currently use synthetic hemp-derived products and may lose access to them or face higher prices on compliant alternatives. Adults aged 18–20 who currently purchase hemp-derived cannabinoid products legally and would be prohibited from doing so. Foreign hemp product producers and importers, who would be barred from the U.S. market by the domestic sourcing requirement. Retailers in states with permissive hemp laws who would face new federal restrictions. Businesses operating in the hemp beverage space, which would be subject to a mandatory three-tier distribution system modeled on alcohol regulation, adding distribution costs.
Supporters argue
Supporters argue that the current regulatory gap — created by the 2018 Farm Bill's broad hemp definition — has allowed a largely unregulated market in high-potency synthetic intoxicants that are frequently sold in convenience stores without age verification, child-safe packaging, or accurate labeling. They contend that products like THC-O-acetate and THCP are chemically distinct from naturally occurring cannabinoids, have no established safety record, and have been linked to adverse events reported to poison control centers. By establishing clear federal standards, mandatory third-party testing, and a dedicated trust fund funded by industry taxes, supporters argue the bill would protect consumers — especially children — while preserving a legitimate, domestically sourced hemp industry.
Opponents argue
Opponents argue that the bill's exclusion of chemically converted cannabinoids is drawn so broadly that it could sweep in widely used, commercially established products like CBD isolates and broad-spectrum extracts that involve some degree of processing, creating legal uncertainty for the entire hemp industry. They contend that the new excise tax structure — a 5% product tax plus a 5% manufacturer revenue tax — amounts to double taxation that would disproportionately burden small producers and drive consumers toward unregulated black markets, as has been observed in states with high cannabis tax rates. Critics also argue that delegating to the Secretary of Agriculture and HHS the authority to expand the list of banned cannabinoids and prohibited production methods grants agencies broad, open-ended rulemaking power that may face heightened judicial scrutiny under the major questions doctrine established in West Virginia v. EPA (2022).
Constitutional context
Congress's authority to regulate hemp commerce rests on the Commerce Clause (Art. I, §8, cl. 3), which Wickard v. Filburn (1942) extended broadly to agricultural products affecting interstate markets. However, the bill's delegation to the Secretary of Agriculture and HHS to define additional banned cannabinoids and prohibited production methods — without fixed statutory criteria — may face challenge under the major questions doctrine (West Virginia v. EPA, 2022) and post-Chevron independent judicial review (Loper Bright v. Raimondo, 2024), particularly given the vast economic significance of the hemp market.
Checks and balances
The executive branch (FDA, USDA, IRS/TTB, and HHS) gains significant new regulatory and enforcement authority over a multi-billion-dollar industry; checks include mandatory notice-and-comment rulemaking, judicial review of permit denials and revocations in federal circuit courts, annual congressional reporting on trust fund expenditures, and the requirement that cannabinoid limits be revisited at least every three years.
Historical precedent
The 2018 Farm Bill first legalized hemp by removing it from the Controlled Substances Act, but left a regulatory vacuum that this bill attempts to fill; the three-tier distribution model mirrors the post-Prohibition alcohol regulatory framework established under the Federal Alcohol Administration Act of 1935.